CTC-AE+

The adverse event logger

Veröffentlicht von: Arpacore

Beschreibung

CTC-AE+ is a browsable reference to the CTC-AE list of adverse event (AE) terms commonly encountered in oncology, plus a portable Adverse Event Logger to keep track of all adverse events during a clinical study.
The CTC-AE 4 and CTC-AE 5 have been developed from the earlier vocabulary known as CTC (Common Toxicity Criteria). Each AE term is defined and accompanied by a grading scale that indicates the severity of the adverse event. All AE terms are organized by the System Organ Classes (SOCs) defined by the Medical Dictionary for Regulatory Activities (MedDRA).
Adverse events are common phenomena affecting patients being treated for cancer. With the availability of new agents and the multimodality interventions, it is critical to monitor systematically the AEs that are linked to oncology research.
CTCAE is fundamentally intended to be an agreed upon terminology for the designation, reporting, and grading of AEs that occur in oncology research.
########################
CTC-AE serves several purposes
########################
- To standardize AE reporting within the NCI oncology research community, across groups and modalities.
- To facilitate the evaluation of new cancer therapies, treatment modalities, and supportive measures.
- To aid in AE recognition and severity grading.
- To monitor safety data and for regulatory reporting.
- To define oncology research protocol parameters (e.g., eligibility criteria; dose-limiting toxicity; maximum tolerated dose; dose modification).
########################
KARNOFSKY and ECOG
########################
Additionally, CTC-AE+ now includes the two most common performance scores. As a reference and as a guided algorithm when necessary to add the event to the patient's record.
########################
ADVERSE EVENT LOGGER
########################
The Adverse Event Logger is a structured local database to help the investigator to keep track of all the adverse events related to the patients participating in a clinical trial.
It is possible to track multiple clinical studies, multiple patients per clinical trial and multiple events per patient. Events can be selected from the CTC-AE 4 and CTC-AE 5 databases, from Karnofsky and ECOG score tables or can be entered as customized events.
For convenience, all data can be exported as an excel CSV file to be imported into other analysis software.
########################
IMPORTANT NOTE
########################
This application is strictly EU GDPR compliant and no clinical study or patient information is saved outside the device or uploaded to any remote cloud resources.
Ausblenden Mehr anzeigen...

In-App-Käufe

Adverse Event Logger
USD 3.99

Screenshots

CTC-AE+ Häufige Fragen

  • Ist CTC-AE+ kostenlos?

    Nein, CTC-AE+ ist nicht kostenlos (es kostet 2.99), und es enthält auch In-App-Käufe.

  • Ist CTC-AE+ seriös?

    Nicht genügend Bewertungen, um eine zuverlässige Einschätzung vorzunehmen. Die App benötigt mehr Nutzerfeedback.

    Danke für die Stimme

  • Wie viel kostet CTC-AE+?

    CTC-AE+ kostet 2.99 zum Herunterladen (und es gibt auch zusätzliche In-App-Käufe).

  • Wie hoch ist der Umsatz von CTC-AE+?

    Um geschätzte Einnahmen der CTC-AE+-App und weitere AppStore-Einblicke zu erhalten, können Sie sich bei der AppTail Mobile Analytics Platform anmelden.

Benutzerbewertung
Die App ist in Ecuador noch nicht bewertet.
Bewertungsverlauf

CTC-AE+ Bewertungen

App doesn’t work

2muchsauc3804 on

Vereinigte Staaten

Don’t bother with this app. It just stays on loading screen forever

Great concept, but needs work

ISM143 on

Vereinigte Staaten

Sadly, poorly designed. Can’t save favorites and search terms are tedious. For example, can’t just search ALT- you have to spell it out. Great concept to have CTC-AE 4 and 5 in one app with performance scales, but please make it more user friendly! For an app that costs 2.99, should be bettter.

Search doesn’t work for titles

Jness09 on

Vereinigte Staaten

Edit 2019. Revising as promised due to developer response. Search “dyspnea”, nothing comes up. “Breath” and dyspnea will show as a search result. Same with fever and most of the AEs I search for. Make titles of the AE terms somehow searchable and I will revise to 5 stars. Until then I’m looking for a different app.

Needs more

Jkap123 on

Vereinigte Staaten

The blood disorders section leaves out thrombocytopenia and leukopenia, for example.

Interesting app

JAG11111 on

Vereinigte Staaten

An interesting and easy to use app. Perhaps adding in more adverse event definitions would be helpful, such as thrombocytopenia and leukopenia.

Add search tab 4 iPad!

Add search on

Vereinigte Staaten

Please add search capacity for iPad.

great!

beansy34 on

Vereinigte Staaten

so much better than carrying around the "not so little" notebook versions. any chance on getting ecog and karnofsky performance scals also?

Excellent program

Oncology MD on

Vereinigte Staaten

As a clinical researcher, I find this program to be a great substitute for the usual spiral notebook!

Store-Rankings

Ranking-Verlauf
App-Ranking-Verlauf noch nicht verfügbar
Kategorien-Rankings
Diagramm
Kategorie
Rang
Top Bezahlt
44
Top Bezahlt
81
Top Bezahlt
82
Top Bezahlt
83
Top Bezahlt
98

CTC-AE+ Konkurrenten

Name
Medical Unit Converter
Convert US & SI Medical Units
Eczema Manager
for Atopic Dermatitis
N/V
inflamación crónica
Infectious Disease Exam Review
Notes flashcards & Concepts
MyREADY Transition CHD App
CTCAE - Terminology 4.03
Therapy Protocols
and Targeted Therapies
HARMAN RCP
TrialKit Coder
WellMamas

CTC-AE+ Installationen

Letzte 30 Tage

CTC-AE+ Umsatz

Letzte 30 Tage

CTC-AE+ Einnahmen und Downloads

Gewinnen Sie wertvolle Einblicke in die Leistung von CTC-AE+ mit unserer Analytik.
Melden Sie sich jetzt an, um Zugriff auf Downloads, Einnahmen und mehr zu erhalten.
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.